A pathology platform · Delaware C-Corp

A precise, modern platform for anatomic pathology laboratories.

AltaPath Inc is a holding company building a network of independently operated pathology laboratories under a shared platform — scientific, calm, deliberate.

EST. 2026  ·  DELAWARE, USA
Structure
Delaware C-Corporation
Focus
Anatomic pathology
Footprint
Multi-state, Southeast US
Model
Network of subsidiaries
Platform

One platform.
Many laboratories.

AltaPath Inc is the parent of a deliberately structured group of healthcare entities. Each subsidiary is purpose-built — clinical operations, management services, and real estate sit in separate vehicles, sharing infrastructure but preserving the integrity of the laboratory practice.

The parent provides capital, governance, and shared services to a network of laboratories that continue to operate under their own clinical leadership. We are not a reference lab and we are not a clinical brand — we are the platform that lets independent laboratories keep doing what they do well, at greater scale and with modern infrastructure.

Subsidiaries handle the work that varies by state and specialty: laboratory operations, management services, and the real estate that anchors each site. The parent handles the work that doesn’t vary — finance, compliance, technology, and long-term strategy.

A note on structure. AltaPath Inc operates a network of subsidiaries, each formed for a specific operational, clinical, or regulatory purpose. Detailed entity information is available on request to qualified counterparties.
Histology laboratory bench with microscope slides and microtome
Approach

How we think about the work.

Three principles shape every laboratory we partner with and every subsidiary we form. They are deliberately conservative — the point is to be the steady party in a moment of change.

01

Operational continuity

Laboratory teams keep their leadership, their staff, and their relationships. The platform takes on the work that pulls them away from the bench — billing, contracts, IT, compliance — and returns the time.

02

Scientific infrastructure

Modern laboratory information systems, digital pathology, and quality programs are deployed once and shared. Scale lets us invest in instruments and software that no single small laboratory could justify.

03

Long-term capital

We capitalize each entity for the work it actually does — clinical, services, or real estate — and hold for the long arc of value creation, not the next quarter. Owners and operators participate in the upside they help build.

Partner with us

Two ways to start a conversation.

We work with two kinds of partners: laboratory owners considering the next chapter of their practice, and capital partners looking for disciplined exposure to healthcare services. Either path begins the same way — a quiet, confidential introduction.

For laboratory owners

You built the practice. We help you decide what comes next.

For owners weighing succession, partnership, or full integration. Conversations are confidential and there is no obligation to proceed.

  • Continue operating under your laboratory’s name and clinical leadership.
  • Offload billing, payer contracts, IT, and compliance overhead.
  • Real estate and operations capitalized in separate, purpose-built entities.
  • Equity rollover available for owners who want continued participation.
For capital partners

Disciplined exposure to a fragmented, defensible market.

For institutional investors and family offices interested in healthcare services with built-in real-asset support. Materials are shared on a confidential basis with qualified counterparties.

  • Multi-state platform with a southeastern footprint.
  • Operating, services, and real-estate entities held under one parent.
  • Long-hold orientation; no public market for interests.
  • Diligence package available on request.
Leadership

The people behind the platform.

AltaPath is led by a small team with combined backgrounds in healthcare operations, clinical management, regulatory compliance, and institutional capital. Detailed biographies are shared on request.

Chief Executive Officer · Chief Investment Officer
Dr. Matthew Sherwood
Chief Operations Officer
Mr. Andrew DeVito